The Real Cost of IVF
Progress Educational Trust
Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent's Park, London NW1 4RG
11 April 2018 6pm (wine reception), 6.30pm-8pm (panel discussion)
The event will be chaired by Sally Cheshire (Chair of the Human Fertilisation and Embryology Authority), with speakers including Professors Lesley Regan (President of the Royal College of Obstetricians and Gynaecologists) and Jacky Boivin (Professor of Health Psychology at Cardiff University) as well as Dr Rebecca Brown (Research Fellow at the University of Oxford's Oxford Uehiro Centre for Practical Ethics) and Jessica Hepburn (author of The Pursuit of Motherhood).
Attendance is free, but advance booking is required. Book your place now by emailing email@example.com
If tweeting about this event, please use the hashtag #RealCostOfIVF
Speakers will address the following questions.
Does receiving fertility treatment confer any benefit to patients, even if there is no baby to take home at the end? Is unsuccessful fertility treatment more devastating than no treatment at all, or is it better to at least have had the chance to try?
How can we assess the costs and benefits of providing fertility treatment?
Quality-adjusted life years (QALYs) are often used to compare the value of treatments for different conditions, but fertility is not easily captured in this way. Whose QALYs should be taken into account - those of an individual patient, a couple, a child conceived via fertility treatment, or a combination of these?
What are the costs of health complications caused by multiple pregnancy following IVF? How could these costs be avoided? What proportion of multiple pregnancies in the UK is attributable to fertility treatment received overseas?
This year, the Royal College of Obstetricians and Gynaecologists has argued that 'multiple pregnancy is the greatest avoidable risk of IVF', that 'the health and financial burdens it places on women, families and the NHS cannot be overstated', and that 'the single most important factor that could enhance the acceptance of elective single embryo transfer among patients and practitioners is the provision of appropriate funding for IVF treatment'.
With decreasing birth rates, an ageing population and the future tax contributions of today's IVF babies to consider, can we afford not to treat infertility?
In the PET tradition, much of the event's running time will be devoted to letting the audience put questions and comments to the speakers.